Dr. John Low Seng Hooi Oncology


Consultant - Oncologist , Experience:

Book Appointment

About Doctor

Dr. John Low Seng Hooi is among the best oncologist in Kuala Lumpur, Malaysia.

Dr John Low obtained his Medical degree (MBBS) from the National University of Singapore in 1996. He received his oncology training at the National Cancer Centre Singapore and the Royal Marsden Hospital, UK.

He obtained his MRCP (UK) in 2001 and FRCR (Clinical Oncology) in 2003. He is the Frank Doyle Medal recipient for the Clinical Oncology Fellowship examination. He is a Fellow of the Academy of Medicine of Singapore (FAMS) as well as a Member of the Malaysian Academy of Medicine (AM). He is also a Fellow of the Royal College of Physicians of Glasgow (FRCP).

Memberships
American Society of Clinical Oncology (ASCO)
American Society for Radiation Oncology (ASTRO)
European Society for Medical Oncology (ESMO)
South East Asia Radiation Oncology Group (SEAROG)
Malaysian Oncological Society (MOS)
Singapore Society of Oncology (SSO)

Awards
ASEAN Scholarship
HMDP Fellowship Award (Singapore Ministry of Health)
Frank Doyle Medal (Royal College of Radiologists, UK)
46th PTCOG Fellowship Award (Paul Scherrer Institut, Switzerland)

Hospital

Pantai Hospital, Kuala Lumpur, Malaysia

Specialization

Procedures Performed

  • Chemotherapy, targeted therapy and immunotherapy
  • Intensity Modulated Radiotherapy (IMRT)
  • Brachytherapy
  • Intraoperative Radiotherapy (IORT)
  • High dose radioactive iodine therapy

Research & Publications

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

×
Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy